Edwards Lifesciences
EW
A$123.49
Share price
2.52%
Change (1 day)
26.73%
Change (1 year)
Categories
Revenue for Edwards Lifesciences (EW)
Revenue in 2025 (TTM): A$8.52 Billion
According to Edwards Lifesciences's latest financial reports the company's current revenue (TTM 
) is A$8.49 Billion. In 2024 the company made a revenue of A$8.77 Billion an increase over the revenue in the year 2023 that were of A$8.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Edwards Lifesciences from 2000 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | A$8.52 B | -2.8% |
| 2024 | A$8.77 B | 8.02% |
| 2023 | A$8.12 B | 2.67% |
| 2022 | A$7.90 B | 9.59% |
| 2021 | A$7.21 B | 26.52% |
| 2020 | A$5.70 B | -8.14% |
| 2019 | A$6.21 B | 17.52% |
| 2018 | A$5.28 B | 20.1% |
| 2017 | A$4.40 B | 7.02% |
| 2016 | A$4.11 B | 20.11% |
| 2015 | A$3.42 B | 20.6% |
| 2014 | A$2.83 B | 23.77% |
| 2013 | A$2.29 B | 25.45% |
| 2012 | A$1.82 B | 11.66% |
| 2011 | A$1.63 B | 14.92% |
| 2010 | A$1.42 B | -3.16% |
| 2009 | A$1.47 B | -16.15% |
| 2008 | A$1.75 B | 40.57% |
| 2007 | A$1.24 B | -5.16% |
| 2006 | A$1.31 B | -3.52% |
| 2005 | A$1.36 B | 13.3% |
| 2004 | A$1.20 B | 3.98% |
| 2003 | A$1.15 B | -7.35% |
| 2002 | A$1.24 B | -7.85% |
| 2001 | A$1.35 B | -9.02% |
| 2000 | A$1.49 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | A$26.93 B | 216.91% | 🇺🇸 USA |
 Merit Medical MMSI | A$2.13 B | -74.93% | 🇺🇸 USA |
 LeMaitre Vascular LMAT | A$0.34 B | -95.92% | 🇺🇸 USA |
 CryoLife CRY | A$0.45 B | -94.60% | 🇺🇸 USA |
 Medtronic MDT | A$51.46 B | 505.49% | 🇮🇪 Ireland |
 ICU Medical
ICUI | A$3.71 B | -56.31% | 🇺🇸 USA |